Avaliação da atividade antitumoral dos complexos de inclusão de ofloxacino com ciclodextrinas em células de câncer de mama MDA-MB-231
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora - Campus Avançado de Governador Valadares
DOI
Abstract
The treatment of breast cancer is complex and often limited by its adverse effects, especially
when it comes to the subtype that does not express hormone receptors and epidermal growth
factor 2. The development of a new drug is expensive and time-consuming, therefore, it is
necessary to search for other strategies for the treatment with better cost-effectiveness, such as
the repositioning of drugs. Fluoroquinolones are antimicrobials, which have cytotoxic activity
in several cancer cell lines reported in studies. Ofloxacin is a second-generation
fluoroquinolone, this drug has a broad spectrum of bactericidal action against Gram-negative
bacteria and Gram-positive by inhibition of DNA gyrase and topoisomerase IV. However,
ofloxacin has low solubility in water, which can hinder its dissolution and bioavailability,
therefore, an alternative to improve these aspects is fundamental. One possibility is
complexation with cyclodextrins, structures capable of modifying physicochemical
characteristics of drugs, including solubility. Thus, the present work sought to evaluate the in
vitro immunomodulation of inclusion complexes of ofloxacin with betacyclodextrin
(OFLOX/βCD) and 2-hydroxypropyl-β-CD (OFLOX/HPβCD), against the breast MDA-MB-
231. It was possible to observe that the cytotoxicity of the OFLOX/βCD and OFLOX/HPβCD
complexes is time and dose dependent. At the highest concentrations (300 μM), the complexes
induced apoptosis and necrosis. The OFLOX/HPβCD complex showed better results than the
OFLOX/βCD complex.
Description
Keywords
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

